811 related articles for article (PubMed ID: 19556829)
21. Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells.
Mueller SO; Simon S; Chae K; Metzler M; Korach KS
Toxicol Sci; 2004 Jul; 80(1):14-25. PubMed ID: 15084758
[TBL] [Abstract][Full Text] [Related]
22. Phytoestrogens activate estrogen receptor beta1 and estrogenic responses in human breast and bone cancer cell lines.
Chrzan BG; Bradford PG
Mol Nutr Food Res; 2007 Feb; 51(2):171-7. PubMed ID: 17266178
[TBL] [Abstract][Full Text] [Related]
23. Combinatory effects of phytoestrogens and 17beta-estradiol on proliferation and apoptosis in MCF-7 breast cancer cells.
Schmidt S; Michna H; Diel P
J Steroid Biochem Mol Biol; 2005 Apr; 94(5):445-9. PubMed ID: 15876409
[TBL] [Abstract][Full Text] [Related]
24. Investigations on cellular proliferation induced by zearalenone and its derivatives in relation to the estrogenic parameters.
Minervini F; Giannoccaro A; Cavallini A; Visconti A
Toxicol Lett; 2005 Dec; 159(3):272-83. PubMed ID: 15994033
[TBL] [Abstract][Full Text] [Related]
25. Phytoestrogens induce differential effects on both normal and malignant human breast cells in vitro.
Chen FP; Chien MH
Climacteric; 2014 Dec; 17(6):682-91. PubMed ID: 24978400
[TBL] [Abstract][Full Text] [Related]
26. Responsiveness to estradiol-17beta and to phytoestrogens in primary human osteoblasts is modulated differentially by high glucose concentration.
Somjen D; Katzburg S; Kohen F; Gayer B; Sharon O; Hendel D; Kaye AM
J Steroid Biochem Mol Biol; 2006 May; 99(2-3):139-46. PubMed ID: 16621514
[TBL] [Abstract][Full Text] [Related]
27. Estrogen receptor-beta regulates psoriasin (S100A7) in human breast cancer.
Skliris GP; Lewis A; Emberley E; Peng B; Weebadda WK; Kemp A; Davie JR; Shiu RP; Watson PH; Murphy LC
Breast Cancer Res Treat; 2007 Jul; 104(1):75-85. PubMed ID: 17009105
[TBL] [Abstract][Full Text] [Related]
28. [The inhibiting effect of genistein on the growth of human breast cancer cells in vitro].
He FJ; Wang J; Niu JZ; Wang JF
Zhongguo Zhong Yao Za Zhi; 2002 Dec; 27(12):936-9. PubMed ID: 12776537
[TBL] [Abstract][Full Text] [Related]
29. The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel.
Czeczuga-Semeniuk E; Jarzabek K; Lemancewicz D; Wołczyński S
Gynecol Endocrinol; 2009 May; 25(5):287-93. PubMed ID: 19340624
[TBL] [Abstract][Full Text] [Related]
30. Phytoestrogen genistein acts as an estrogen agonist on human osteoblastic cells through estrogen receptors alpha and beta.
Rickard DJ; Monroe DG; Ruesink TJ; Khosla S; Riggs BL; Spelsberg TC
J Cell Biochem; 2003 Jun; 89(3):633-46. PubMed ID: 12761896
[TBL] [Abstract][Full Text] [Related]
31. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
32. Physiological concentrations of genistein and 17β-estradiol inhibit MDA-MB-231 breast cancer cell growth by increasing BAX/BCL-2 and reducing pERK1/2.
Rajah TT; Peine KJ; Du N; Serret CA; Drews NR
Anticancer Res; 2012 Apr; 32(4):1181-91. PubMed ID: 22493348
[TBL] [Abstract][Full Text] [Related]
33. Membranal effects of phytoestrogens and carboxy derivatives of phytoestrogens on human vascular and bone cells: new insights based on studies with carboxy-biochanin A.
Somjen D; Kohen F; Lieberherr M; Gayer B; Schejter E; Katzburg S; Limor R; Sharon O; Knoll E; Posner GH; Kaye AM; Stern N
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):293-303. PubMed ID: 15860273
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of an estrogen receptor beta-selective radioligand: 5-[18F]fluoro-(2R,3S)-2,3-bis(4-hydroxyphenyl)pentanenitrile and comparison of in vivo distribution with 16alpha-[18F]fluoro-17beta-estradiol.
Yoo J; Dence CS; Sharp TL; Katzenellenbogen JA; Welch MJ
J Med Chem; 2005 Oct; 48(20):6366-78. PubMed ID: 16190762
[TBL] [Abstract][Full Text] [Related]
35. The effects of estrogen receptors α- and β-specific agonists and antagonists on cell proliferation and energy metabolism in human bone cell line.
Somjen D; Katzburg S; Sharon O; Grafi-Cohen M; Knoll E; Stern N
J Cell Biochem; 2011 Feb; 112(2):625-32. PubMed ID: 21268084
[TBL] [Abstract][Full Text] [Related]
36. Effects of diverse dietary phytoestrogens on cell growth, cell cycle and apoptosis in estrogen-receptor-positive breast cancer cells.
Sakamoto T; Horiguchi H; Oguma E; Kayama F
J Nutr Biochem; 2010 Sep; 21(9):856-64. PubMed ID: 19800779
[TBL] [Abstract][Full Text] [Related]
37. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
Lindberg K; Ström A; Lock JG; Gustafsson JA; Haldosén LA; Helguero LA
J Cell Physiol; 2010 Jan; 222(1):156-67. PubMed ID: 19780039
[TBL] [Abstract][Full Text] [Related]
38. Genistein modulates oxidative stress in breast cancer cell lines according to ERα/ERβ ratio: effects on mitochondrial functionality, sirtuins, uncoupling protein 2 and antioxidant enzymes.
Nadal-Serrano M; Pons DG; Sastre-Serra J; Blanquer-Rosselló Mdel M; Roca P; Oliver J
Int J Biochem Cell Biol; 2013 Sep; 45(9):2045-51. PubMed ID: 23871935
[TBL] [Abstract][Full Text] [Related]
39. Expression of ERalpha and ERbeta in lobular carcinoma in situ.
Middleton LP; Perkins GH; Tucker SL; Sahin AA; Singletary SE
Histopathology; 2007 Jun; 50(7):875-80. PubMed ID: 17543077
[TBL] [Abstract][Full Text] [Related]
40. Distinct mRNA, protein expression patterns and distribution of oestrogen receptors alpha and beta in human primary breast cancer: correlation with proliferation marker Ki-67 and clinicopathological factors.
Jarzabek K; Koda M; Kozlowski L; Mittre H; Sulkowski S; Kottler ML; Wolczynski S
Eur J Cancer; 2005 Dec; 41(18):2924-34. PubMed ID: 16289616
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
